The Role of Vitamin D3 Deficiency and Colonization of the Oral Mucosa by Yeast-like Fungi in the Pathomechanism of Psoriasis.

Mariola Marchlewicz, Paulina Sagan, Marta Grabowska, Magdalena Kiedrowicz, Joanna Kruk, Kamil Gill, Małgorzata Piasecka, Ewa Duchnik
Author Information
  1. Mariola Marchlewicz: Department of Dermatology and Venereology, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 70-010 Police, Poland.
  2. Paulina Sagan: Department of Dermatology and Venereology, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 70-010 Police, Poland.
  3. Marta Grabowska: Department of Histology and Developmental Biology, Faculty of Health Sciences, Pomeranian Medical University, 71-210 Szczecin, Poland. ORCID
  4. Magdalena Kiedrowicz: Department of Dermatology and Venereology, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 70-010 Police, Poland.
  5. Joanna Kruk: Faculty of Physical Culture and Health, University of Szczecin, 71-065 Szczecin, Poland.
  6. Kamil Gill: Department of Histology and Developmental Biology, Faculty of Health Sciences, Pomeranian Medical University, 71-210 Szczecin, Poland. ORCID
  7. Małgorzata Piasecka: Department of Histology and Developmental Biology, Faculty of Health Sciences, Pomeranian Medical University, 71-210 Szczecin, Poland. ORCID
  8. Ewa Duchnik: Department of Aesthetic Dermatology, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.

Abstract

Psoriasis is a chronic inflammatory skin disease with complex pathogenesis and variable severity. Performed studies have indicated the impact of vitamin D3 deficiency on the pathogenesis of psoriasis and its severity. However, there is no clear evidence of the influence of the mucosal microbiome on the onset and progression of psoriasis. This review aims to present the current evidence on the role of vitamin D3 and colonization of the oral mucosa by yeast-like fungi in the pathogenesis of psoriasis. is a common yeast that can colonize the skin and mucosal surfaces, particularly in individuals with weakened immune systems or compromised skin barriers. In psoriasis, the skin's barrier function is disrupted, potentially making patients more susceptible to fungal infections such as . Since patients with psoriasis are at increased risk of metabolic syndrome, they may experience the vicious circle effect in which chronic inflammation leads to obesity. Vitamin D3 deficiency is also associated with microbiological imbalance, which may promote excessive growth of fungi. Under normal conditions, the intestinal and oral microflora support the immune system. Vitamin D3 deficiency, however, leads to disruption of this balance, which allows to overgrow and develop infections.

Keywords

References

  1. Postepy Hig Med Dosw (Online). 2017 Aug 28;71(1):797-810 [PMID: 28894040]
  2. Cell Microbiol. 2006 Apr;8(4):668-76 [PMID: 16548892]
  3. Front Med (Lausanne). 2018 Feb 13;5:28 [PMID: 29487851]
  4. Reumatismo. 2007;59 Suppl 1:46-8 [PMID: 17828343]
  5. Nat Rev Immunol. 2018 Feb;18(2):134-147 [PMID: 28990587]
  6. Curr Pharm Biotechnol. 2021;22(13):1812-1820 [PMID: 33602072]
  7. J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e857-e859 [PMID: 34363647]
  8. J Am Acad Dermatol. 2022 Jul;87(1):183-184 [PMID: 34416293]
  9. Isr Med Assoc J. 2017 Jul;19(7):438-443 [PMID: 28786260]
  10. J Biol Chem. 2006 Dec 15;281(50):38854-66 [PMID: 17050534]
  11. Indian J Dermatol. 2022 Nov-Dec;67(6):662-666 [PMID: 36998885]
  12. Proc Nutr Soc. 2001 Aug;60(3):349-56 [PMID: 11681809]
  13. Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16465-16474 [PMID: 32601220]
  14. PLoS Pathog. 2019 Nov 6;15(11):e1008096 [PMID: 31693704]
  15. Mediators Inflamm. 2018 May 6;2018:9602362 [PMID: 29853795]
  16. Noncoding RNA Res. 2020 Jul 03;5(3):99-108 [PMID: 32695942]
  17. Asian Pac J Cancer Prev. 2014;15(2):561-8 [PMID: 24568458]
  18. Cutis. 2018 Nov;102(5S):18-20 [PMID: 30566552]
  19. Am J Hum Genet. 2006 May;78(5):827-851 [PMID: 16642438]
  20. Curr Opin Microbiol. 2019 Dec;52:1-6 [PMID: 31085405]
  21. Front Immunol. 2021 Oct 18;12:764384 [PMID: 34733291]
  22. Cell Death Dis. 2020 Jun 9;11(6):444 [PMID: 32518230]
  23. Clin Dermatol. 2015 Jul-Aug;33(4):456-61 [PMID: 26051061]
  24. J Invest Dermatol. 1999 Jan;112(1):32-5 [PMID: 9886260]
  25. Br Dent J. 1996 Nov 9;181(9):336-8 [PMID: 8972954]
  26. Circulation. 2009 Oct 20;120(16):1640-5 [PMID: 19805654]
  27. Nat Rev Dis Primers. 2018 May 11;4:18026 [PMID: 29749387]
  28. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Oct;122(4):448-54 [PMID: 27567434]
  29. J Clin Invest. 1994 Jul;94(1):202-9 [PMID: 8040262]
  30. Int J Mol Sci. 2022 Oct 12;23(20): [PMID: 36292991]
  31. Reumatologia. 2023;61(2):116-122 [PMID: 37223373]
  32. J Reprod Immunol. 2017 Jun;121:42-48 [PMID: 28622535]
  33. Arch Intern Med. 2007 Aug 13-27;167(15):1670-5 [PMID: 17698691]
  34. Medicine (Baltimore). 2018 Jul;97(27):e11394 [PMID: 29979432]
  35. J Invest Dermatol. 2008 Nov;128(11):2640-2645 [PMID: 18615114]
  36. Psoriasis (Auckl). 2017 Dec 07;7:87-94 [PMID: 29387611]
  37. J Eur Acad Dermatol Venereol. 2012 Nov;26(11):1345-53 [PMID: 22385402]
  38. Front Immunol. 2019 Jun 25;10:1440 [PMID: 31293591]
  39. J Dent Res. 2016 Apr;95(4):365-71 [PMID: 26747422]
  40. Psoriasis (Auckl). 2022 Jul 02;12:189-197 [PMID: 35813078]
  41. Am J Clin Nutr. 2000 Sep;72(3):690-3 [PMID: 10966885]
  42. J Fungi (Basel). 2018 Jan 11;4(1): [PMID: 29371503]
  43. Nutrients. 2020 Jul 15;12(7): [PMID: 32679784]
  44. N Engl J Med. 2011 Aug 18;365(7):620-8 [PMID: 21848462]
  45. Commun Biol. 2021 Mar 25;4(1):401 [PMID: 33767430]
  46. J Am Acad Dermatol. 1985 Sep;13(3):450-6 [PMID: 4056119]
  47. Psoriasis (Auckl). 2019 Jan 17;9:1-6 [PMID: 30697518]
  48. Br J Dermatol. 2003 Dec;149(6):1305-6 [PMID: 14674922]
  49. Int J Mol Sci. 2020 Sep 16;21(18): [PMID: 32947991]
  50. Clin Dermatol. 2018 Jan - Feb;36(1):21-28 [PMID: 29241748]
  51. AIDS Patient Care STDS. 2000 May;14(5):239-46 [PMID: 10833810]
  52. J Hum Nutr Diet. 2019 Aug;32(4):512-517 [PMID: 30773722]
  53. Front Cell Infect Microbiol. 2019 Feb 04;9:7 [PMID: 30778377]
  54. Dermatol Reports. 2021 Mar 17;13(1):8811 [PMID: 33824705]
  55. J Autoimmun. 2017 Dec;85:78-97 [PMID: 28733125]
  56. Annu Rev Microbiol. 2000;54:49-79 [PMID: 11018124]
  57. J Mycol Med. 2017 Mar;27(1):79-82 [PMID: 27865660]
  58. Aust Dent J. 2010 Jun;55 Suppl 1:48-54 [PMID: 20553244]
  59. Cancer Causes Control. 2015 Jun;26(6):881-91 [PMID: 25791130]
  60. Front Physiol. 2021 Sep 24;12:737709 [PMID: 34630157]
  61. J Inflamm Res. 2022 Mar 31;15:2157-2166 [PMID: 35386225]
  62. Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):135-44 [PMID: 26924402]
  63. J Am Acad Dermatol. 2015 Feb;72(2):261-75 [PMID: 25455609]
  64. Front Immunol. 2021 Jul 23;12:711060 [PMID: 34367173]
  65. Cold Spring Harb Perspect Med. 2014 Aug 01;4(8): [PMID: 25085957]
  66. Physiol Rev. 2016 Jan;96(1):365-408 [PMID: 26681795]
  67. Life Sci. 2005 Aug 12;77(13):1502-15 [PMID: 15979653]
  68. J Fungi (Basel). 2020 Jan 16;6(1): [PMID: 31963180]
  69. Clin Microbiol Rev. 2004 Apr;17(2):255-67 [PMID: 15084500]
  70. J Infect Dis. 2015 Aug 15;212(4):635-44 [PMID: 25612733]
  71. Br J Sports Med. 2020 Dec;54(24):1451-1462 [PMID: 33239350]
  72. Nutrients. 2023 Feb 07;15(4): [PMID: 36839198]
  73. Postepy Hig Med Dosw (Online). 2017 Aug 24;71(1):761-772 [PMID: 28894050]
  74. J Allergy Clin Immunol. 2011 Mar;127(3):787-94.e1-9 [PMID: 21377044]
  75. Reumatologia. 2017;55(3):131-135 [PMID: 28769136]
  76. Rev Endocr Metab Disord. 2017 Jun;18(2):195-205 [PMID: 28176237]
  77. J R Coll Physicians Edinb. 2013;43(4):334-8; quiz 339 [PMID: 24350319]
  78. Br J Dermatol. 1968 Dec;80(12):771-93 [PMID: 4236712]
  79. Am Fam Physician. 2013 May 1;87(9):626-33 [PMID: 23668525]
  80. Endokrynol Pol. 2013;64(4):319-27 [PMID: 24002961]
  81. Front Med (Lausanne). 2023 May 25;10:1203426 [PMID: 37305120]
  82. Nutrients. 2021 Dec 28;14(1): [PMID: 35010995]
  83. J Eur Acad Dermatol Venereol. 2002 May;16(3):241-8 [PMID: 12195563]
  84. J Am Acad Dermatol. 2012 Nov;67(5):931-8 [PMID: 22387034]
  85. Acta Derm Venereol. 2018 Dec 27;99(1):18-25 [PMID: 30085329]
  86. Postepy Hig Med Dosw (Online). 2014;68:865-78 [PMID: 24988607]
  87. Int J Mol Sci. 2021 Apr 13;22(8): [PMID: 33924414]
  88. J Dermatol. 2012 Mar;39(3):212-8 [PMID: 22035413]
  89. Clin Nutr Res. 2021 Jul 20;10(3):181-191 [PMID: 34386438]
  90. Am J Pathol. 2008 Apr;172(4):961-71 [PMID: 18349121]
  91. Front Microbiol. 2020 Dec 15;11:589726 [PMID: 33384669]
  92. Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii18-23; discussion ii24-5 [PMID: 15708928]
  93. Nat Rev Microbiol. 2011 Dec 12;10(2):112-22 [PMID: 22158429]
  94. J Clin Aesthet Dermatol. 2010 Jan;3(1):32-8 [PMID: 20725536]
  95. Rev Endocr Metab Disord. 2012 Mar;13(1):3-19 [PMID: 21845365]
  96. J Am Acad Dermatol. 2014 Dec;71(6):1053.e1-1053.e16 [PMID: 25454037]
  97. J Clin Med. 2023 Sep 06;12(18): [PMID: 37762741]
  98. J Adv Res. 2015 Nov;6(6):793-804 [PMID: 26644915]
  99. Sci Rep. 2016 Aug 05;6:31119 [PMID: 27493143]
  100. Int J Mol Sci. 2019 Sep 05;20(18): [PMID: 31491865]
  101. J Exp Med. 2009 Aug 31;206(9):2037-51 [PMID: 19703985]
  102. Curr Obes Rep. 2021 Jun;10(2):162-180 [PMID: 33792853]
  103. Indian J Dermatol Venereol Leprol. 2017 Jul-Aug;83(4):415-423 [PMID: 28195077]
  104. Mycoses. 2022 Feb;65(2):247-254 [PMID: 34787934]
  105. Int J Mol Sci. 2019 Mar 23;20(6): [PMID: 30909615]
  106. Hepatology. 2018 Oct;68(4):1604-1620 [PMID: 29633303]
  107. Nutrients. 2022 Jun 27;14(13): [PMID: 35807833]

Grants

  1. WNoZ-324/S/2024/Pomeranian Medical University

Word Cloud

Created with Highcharts 10.0.0D3psoriasisskinpathogenesisvitamindeficiencyoralVitaminPsoriasischronicseverityevidencemucosalmucosafungiimmunepatientsinfectionsmayleadsinflammatorydiseasecomplexvariablePerformedstudiesindicatedimpactHoweverclearinfluencemicrobiomeonsetprogressionreviewaimspresentcurrentrolecolonizationyeast-likecommonyeastcancolonizesurfacesparticularlyindividualsweakenedsystemscompromisedbarriersskin'sbarrierfunctiondisruptedpotentiallymakingsusceptiblefungalSinceincreasedriskmetabolicsyndromeexperienceviciouscircleeffectinflammationobesityalsoassociatedmicrobiologicalimbalancepromoteexcessivegrowthnormalconditionsintestinalmicroflorasupportsystemhoweverdisruptionbalanceallowsovergrowdevelopRoleDeficiencyColonizationOralMucosaYeast-likeFungiPathomechanismCandida

Similar Articles

Cited By